“Young Blood” Transfusions Are Not Ready For Primetime – Yet

“Young Blood” Transfusions Are Not Ready For Primetime – Yet

A young woman donates blood.

(© Aidman/Fotolia)


Keep Reading Keep Reading
James Peyer
James Peyer, Ph.D. was only sixteen when he decided he would dedicate his life to preventing the diseases of aging. In 2016 he founded Apollo Ventures (www.apollo.vc), an early-stage venture capital firm and incubator with a focus on biotech companies that are creating the next generation of medicines: therapeutics to prevent age-related disease and extend healthy lifespan. Before Apollo he was a consultant with McKinsey & Company's biotech and pharma practice, where he specialized in biotech entrepreneurship, drug launches for regenerative medicines, and R&D pipeline analysis. He founded his first company, Genotyp, at age 21 to overhaul hands-on science education in the US. The first biotech company to receive funding through Kickstarter, Genotyp's biotech equipment leasing model and instructor training earned it the approval of the White House and the NIH. James received a BA in biology with special honors from the University of Chicago, where he was a National Merit Scholar. He received his Ph.D. from the University of Texas Southwestern Medical Center in Dallas, where he was a National Science Foundation Fellow with a focus on the basic biology of stem cells and improving gene therapies. The author declares no conflict of financial interest with the article written above.
MILESTONE: Doctors have transplanted a pig organ into a human for the first time in history

A surgeon at Massachusetts General Hospital prepares a pig organ for transplant.

Michelle Rose/Massachusetts General Hospital

Surgeons at Massachusetts General Hospital made history last week when they successfully transplanted a pig kidney into a human patient for the first time ever.

The recipient was a 62-year-old man named Richard Slayman who had been living with end-stage kidney disease caused by diabetes. While Slayman had received a kidney transplant in 2018 from a human donor, his diabetes ultimately caused the kidney to fail less than five years after the transplant. Slayman had undergone dialysis ever since—a procedure that uses an artificial kidney to remove waste products from a person’s blood when the kidneys are unable to—but the dialysis frequently caused blood clots and other complications that landed him in the hospital multiple times.

Keep Reading Keep Reading
Sarah Watts

Sarah Watts is a health and science writer based in Chicago.

The World’s First Longevity Charter City: An interview with Niklas Anzinger.

Niklas Anzinger is the founder of Infinita VC based in the charter city of Prospera in Honduras. Infinita focuses on a new trend of charter cities and other forms of alternative jurisdictions. Healso hosts a podcast about how to accelerate the future by unblocking “stranded technologies”.This spring he was a part of the network city experiment Zuzalu spearheaded by Ethereum founder Vitalik Buterin where a few hundred invited guests from the spheres of longevity, biotechnology, crypto, artificial intelligence and investment came together to form a two-monthlong community. It has been described as the world’s first pop-up city. Every morning Vitalians would descend on a long breakfast—the menu had been carefully designed by famed radical longevity self-experimenter Bryan Johnson—and there is where I first met Anzinger who told me about Prospera. Intrigued to say the least, I caught up with him later the same week and the following is a record of our conversation.

Keep Reading Keep Reading
Ingemar Patrick Linden
Driven by a passion to probe the fundamental questions we are confronted with, Dr. INGEMAR PATRICK LINDEN has been on a journey of discovery taking him from Lund University in Sweden, to UCL in London, to University of California, to New York, where he has taught philosophy for almost a decade. Death. It does not get more fundamental than that. One of the ideas that has remained a firm conviction of the author’s since childhood is that we do not have enough time. We are but the beginnings of complete humans, fragments of what we could be. It was the realization that not all share this view, in fact, surveys show that most do not, that inspired, and necessitated, the writing of THE CASE AGAINST DEATH.